TASIGNA caps 50 mg 120 pce

7680580070056 CH-58007 L01EA03 07.16.1.

Reimbursement limitations:

TASIGNA

Traitement des patients avec une leucémie myéloïde chronique à chromosome philadelphia positif (Ph+ CML) en …

TASIGNA caps 50 mg 120 pce
TASIGNA caps 50 mg 120 pce
1 / 2
google

Details

Product number
5800703
CPT
-
Packaging group
120
Unit
Kapsel(n)
Composition
nilotinibum 50 mg ut nilotinibi hydrochloridum monohydricum, lactosum monohydricum 39.025 mg, crospovidonum, poloxamerum, silica colloidalis anhydrica, magnesii stearas, Kapselhülle: gelatina, E 171, E 172 (flavum), E 172 (rubrum), Drucktinte: lacca, E 172 (nigrum), propylenglycolum, ammoniae solutio 28 per centum, pro capsula.

Articles (1)

Tasigna 50 mg, Kapseln
Kapseln
120
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
09/08/2022
Patient information leaflet
Français
09/08/2022
Patient information leaflet
Italien
09/08/2022
Professional SmPC
Allemand
09/08/2022
Professional SmPC
Français
09/08/2022
Professional SmPC
Italien
09/08/2022

Detailed composition

Substance Quantity Type Category
(N/A)
50.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
39.025 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
- Substance FTODK
(N/A)
- Substance FTODK
(N/A)
- Substance HNIDK
(N/A)
- Substance FTODK
(N/A)
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
(N/A)
- Substance HNIDK

Authorization holder

Novartis Pharma Schweiz AG

6343 Risch

Authorization information

Swissmedic authorization number
58007
Drug name
Tasigna, Kapseln
Galenic form
KAHA
ATC Code
L01EA03
Authorization status
Z
Dispensation category
A
First authorization
24/07/2007
Authorization expiration date
31/12/9999
IT number
07.16.1.
Domain
Human medicine
Field of application
Behandlung der chronischen myeloischen Leukämie

Packaging details

Description (FR)
TASIGNA caps 50 mg 120 pce
Description (DE)
TASIGNA Kaps 50 mg 120 Stk
Market launch
31/01/2018
Narcotic (BTM)
No

Available generics

Other packaging sizes

TASIGNA caps 200 mg 28 pce
28 KAP
GTIN: 7680580070018
View
TASIGNA caps 200 mg 112 pce
112 KAP
GTIN: 7680580070025
View
TASIGNA caps 150 mg 112 pce
112 KAP
GTIN: 7680580070049
View